IGF-1R inhibition induced activation of Yes/SFK acts as a by-pass resistance pathway in rhabdomyosarcoma

被引：0
|
作者：
Wan, X. [1 ]
Yeung, C. [1 ]
Heske, C. [1 ]
Mendoza, A. [1 ]
HIman, L. J. [1 ]
机构：
[1] NCI, Pediat Oncol Branch, Bethesda, MD 20892 USA
来源：
EUROPEAN JOURNAL OF CANCER | 2014年 / 50卷
关键词：
D O I：
10.1016/S0959-8049(14)70437-X
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
311
引用
收藏
页码：101 / 101
页数：1
相关论文
共 50 条
  • [11] The IGF-1R pathway in NSCLC. Expression, mutational analysis and activation by hypoxia
    Forde, L.
    Gately, K.
    Gray, S. G.
    O'Byrne, K. J.
    LUNG CANCER, 2010, 67 : S1 - S1
  • [12] A RATIONAL BASIS FOR TARGETING IGF-1R WITH EGFR IN HEPATOCELLULAR CARCINOMA: THE ACTIVATION OF AN EGFR/HER-3/AKT-DEPENDENT SIGNALLING PATHWAY COMPENSATES FOR THE SPECIFIC INHIBITION OF IGF-1R IN HEPATOMA CELLS
    Desbois-Mouthon, Christele
    Baron, Aurore
    Van-Eggelpoel, Marie-Jose
    Venot, Corinne
    Bladt, Friedhelm
    Poupon, Raoul
    Housset, Chantal
    Rosmorduc, Olivier
    HEPATOLOGY, 2008, 48 (04) : 1122A - 1122A
  • [13] ERK Phosphorylation Is Predictive of Resistance to IGF-1R Inhibition in Small Cell Lung Cancer
    Zinn, Rebekah L.
    Gardner, Eric E.
    Marchionni, Luigi
    Murphy, Sara C.
    Dobromilskaya, Irina
    Hann, Christine L.
    Rudin, Charles M.
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (06) : 1131 - 1139
  • [14] Insulin deficiency induces rat renal mesangial cell dysfunction via activation of IGF-1/IGF-1R pathway
    Ya-li Kong
    Yang Shen
    Jun Ni
    De-cui Shao
    Nai-jun Miao
    Jin-lan Xu
    Li Zhou
    Hong Xue
    Wei Zhang
    Xiao-xia Wang
    Li-min Lu
    Acta Pharmacologica Sinica, 2016, 37 : 217 - 227
  • [15] Compensatory Insulin Receptor (IR) Activation on Inhibition of Insulin-Like Growth Factor-1 Receptor (IGF-1R): Rationale for Cotargeting IGF-1R and IR in Cancer
    Buck, Elizabeth
    Gokhale, Prafulla C.
    Koujak, Susan
    Brown, Eric
    Eyzaguirre, Alexandra
    Tao, Nianjun
    Rosenfeld-Franklin, Maryland
    Lerner, Lorena
    Chiu, M. Isabel
    Wild, Robert
    Epstein, David
    Pachter, Jonathan A.
    Miglarese, Mark R.
    MOLECULAR CANCER THERAPEUTICS, 2010, 9 (10) : 2652 - 2664
  • [16] IGF-1R pathway activation as putative biomarker for linsitinib therapy to revert tamoxifen resistance in ER-positive breast cancer
    Kruger, Dinja T.
    Alexi, Xanthippi
    Opdam, Mark
    Schuurman, Karianne
    Voorwerk, Leonie
    Sanders, Joyce
    van der Noort, Vincent
    Boven, Epie
    Zwart, Wilbert
    Linn, Sabine C.
    INTERNATIONAL JOURNAL OF CANCER, 2020, 146 (08) : 2348 - 2359
  • [17] Exendin-4 enhances proliferation of senescent osteoblasts through activation of the IGF-1/IGF-1R signaling pathway
    Zhang, Mengjun
    Xie, Yunzhen
    Zhou, Yu
    Chen, Xinwei
    Xin, Zhiming
    An, Jingjing
    Hou, Jianming
    Chen, Zhou
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2019, 516 (01) : 300 - 306
  • [18] Insulin deficiency induces rat renal mesangial cell dysfunction via activation of IGF-1/IGF-1R pathway
    Kong, Ya-li
    Shen, Yang
    Ni, Jun
    Shao, De-cui
    Miao, Nai-jun
    Xu, Jin-lan
    Zhou, Li
    Xue, Hong
    Zhang, Wei
    Wang, Xiao-xia
    Lu, Li-min
    ACTA PHARMACOLOGICA SINICA, 2016, 37 (02) : 217 - 227
  • [19] The IGF-1R/AKT pathway has opposing effects on Nutlin-3a-induced apoptosis
    Davaadelger, Batzaya
    Perez, Ricardo E.
    Zhou, Yalu
    Duan, Lei
    Gitelis, Steven
    Maki, Carl G.
    CANCER BIOLOGY & THERAPY, 2017, 18 (11) : 895 - 903
  • [20] Quantitative analysis of IGF-1R expression and signaling pathway activation in FFPE xenograft and human tumor tissues
    Thyparambil, Sheeno
    Hembrough, Todd
    Cao, Liang
    Krizman, David
    Darfler, Marlene
    Burrows, Jon
    Helman, Lee
    CANCER RESEARCH, 2011, 71
12345